Arteslide L Dry Syrup
Artemether + Lumefantrine Pediatric Anti-Malarial Dry Syrup
Arteslide L Dry Syrup is a pediatric anti-malarial formulation containing Artemether and Lumefantrine, developed for the effective treatment of malaria infections in children. This combination belongs to the artemisinin-based combination therapy (ACT) class, which is widely used for the treatment of Plasmodium falciparum malaria.
Arteslide L Dry Syrup is specially formulated for pediatric use and is supplied as a dry syrup with water for reconstitution, making it convenient for accurate dosing and easy administration in children. The product is marketed under the Tinybud Pediatrics Division of Cafoli Lifecare Pvt. Ltd., offering reliable pediatric medicines for pharma distributors, medical agencies, and PCD pharma franchise partners.
The Artemether + Lumefantrine combination works through a dual mechanism. Artemether helps rapidly reduce the number of malaria parasites in the blood, while Lumefantrine helps eliminate remaining parasites and prevent recurrence of infection.
Product Composition
Composition:
Artemether – 40 mg / 5 ml
Lumefantrine – 240 mg / 5 ml
Dosage Form
Dry Syrup (for oral suspension after reconstitution)
Packaging Details
Packaging Type: Vial with Water for Reconstitution
Pack Size: Mono Carton
MRP: ₹177/-
Therapeutic Category
Anti-Malarial Medicine
Artemisinin-Based Combination Therapy (ACT)
Indications
Arteslide L Dry Syrup may be prescribed for the treatment of:
Use strictly as directed by a registered medical practitioner.
What is Special in Arteslide L Dry Syrup
Artemisinin-Based Combination Therapy (ACT)
The combination of Artemether and Lumefantrine is widely recommended in malaria treatment protocols because it uses two different anti-malarial agents with complementary actions.
Dual Mechanism Action
Pediatric-Friendly Formulation
The dry syrup dosage form allows convenient reconstitution and accurate dosing for children.
Reliable Packaging
The product is supplied with water for reconstitution, ensuring proper preparation of the suspension before use.
Key Features
-
Pediatric anti-malarial dry syrup formulation
-
Combination of Artemether and Lumefantrine
-
Suitable for pediatric malaria treatment
-
Easy-to-administer oral suspension
-
Convenient vial with water packaging
-
Suitable for hospital and pediatric prescription segment
Market Potential for Pharma Distributors
Anti-malarial medicines remain an important segment in many regions due to seasonal and regional malaria incidence. Arteslide L Dry Syrup offers good marketing potential for:
-
Pharma distributors
-
PCD pharma franchise partners
-
Medical agencies
-
Pediatric medicine suppliers
-
Wholesale pharmaceutical buyers
This product fits well within pediatric therapy portfolios, especially in regions where malaria management medicines are regularly prescribed.
Business Opportunities
Arteslide L Dry Syrup is available for:
Through the Tinybud Pediatrics Division of Cafoli Lifecare Pvt. Ltd..
Medical Disclaimer
This product should be used only under the supervision of a registered medical practitioner.
The information provided is for educational and product information purposes only and should not replace professional medical advice, diagnosis, or treatment.